CIK 0000725363 · Non-accelerated filer<br>Smaller reporting company
CEL SCI CORP
Sign in to watch- Ticker
- CVM
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Sep 30
- Incorporated
- CO
- Entity type
- operating
- EIN
- 840916344
- Phone
- 7035069460
- Business address
- 8229 BOONE BLVD ., SUITE 802, VIENNA, VA, 22182
- Open-market buys, last 90 days
- $138,000
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$138,000. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-31 | PRICHEP PATRICIA B Chief Financial Officer | Grant or award | +815 | $5.26 | $4K | 12,028 |
| 2025-12-31 | KERSTEN GEERT R Chief Executive Officer | Grant or award | +998 | $5.26 | $5K | 82,792 |
| 2025-12-04 | KERSTEN GEERT R Chief Executive Officer | Purchase | +8,389 | $5.96 | $50K | 81,794 |
| 2025-09-30 | TALOR EYAL Chief Scientific Officer | Grant or award | +260 | $9.20 | $2K | 5,808 |
| 2025-09-30 | PRICHEP PATRICIA B Chief Financial Officer | Grant or award | +466 | $9.20 | $4K | 11,213 |
| 2025-09-30 | KERSTEN GEERT R Chief Executive Officer | Grant or award | +570 | $9.20 | $5K | 73,405 |
| 2025-07-28 | Watson Robert Eugene Director | Grant or award · Options | +4,000 | $0.01 | $40 | 27,266 |
| 2025-07-28 | BAILLAVOINE BRUNO JEAN-MARIE Director | Grant or award · Options | +4,000 | $0.01 | $40 | 28,017 |
| 2025-07-28 | CIPRIANO JOHN Senior Vice President | Grant or award · Options | +7,500 | $0.01 | $75 | 38,008 |
| 2025-07-28 | TALOR EYAL Chief Scientific Officer | Grant or award · Options | +15,000 | $0.01 | $150 | 81,622 |
| 2025-07-28 | PRICHEP PATRICIA B Chief Financial Officer | Grant or award · Options | +12,000 | $0.01 | $120 | 75,127 |
| 2025-07-28 | KERSTEN GEERT R Chief Executive Officer | Grant or award · Options | +25,000 | $0.01 | $250 | 175,157 |
| 2025-07-25 | Watson Robert Eugene Director | Purchase | +2,919 | $6.85 | $20K | 3,733 |
| 2025-07-25 | KERSTEN GEERT R Chief Executive Officer | Purchase | +29,197 | $6.85 | $200K | 72,835 |
| 2025-06-30 | TALOR EYAL Chief Scientific Officer | Grant or award | +1,048 | $2.29 | $2K | 5,548 |
| 2025-06-30 | PRICHEP PATRICIA B Chief Financial Officer | Grant or award | +1,873 | $2.29 | $4K | 10,747 |
| 2025-06-30 | KERSTEN GEERT R Chief Executive Officer | Grant or award | +2,292 | $2.29 | $5K | 43,638 |
| 2025-03-31 | TALOR EYAL Chief Scientific Officer | Grant or award | +10,416 | $0.23 | $2K | 135,013 |
| 2025-03-31 | PRICHEP PATRICIA B Chief Financial Officer | Grant or award | +15,432 | $0.23 | $4K | 266,230 |
| 2025-03-31 | KERSTEN GEERT R Chief Executive Officer | Grant or award | +22,786 | $0.23 | $5K | 1,240,378 |
Page 2 of 5 · 100 trades